About this trial
PURPOSE:
This study will be conducted to investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction BACKGROUND: Sacroiliac joint (SIJ) pain is pain arising from SIJ structures and SIJ dysfunction (SIJD) generally refers to aberrant position or movement of SIJ structures . An estimated 15-30% of all low back pain cases are due to SIJ pain The present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction
HYPOTHESES:
. •There will be no effect of BMI on gluteus maximum activity in adulthood with sacroiliac dysfunction
RESEARCH QUESTION:
* Do BMI has an effect on gluteus maximum activity in adulthood with sacroiliac dysfunction?
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Their ages will range from 20-40 years old.
Their BMI will be less than 20- 30kg/m2.
All of them suffer from mild to moderate degree of sacroiliac pain.
The subjects complain from sacroiliac pain for 1 month ago
Disqualifiers
inflammatory diseases or any rheumatic disorders,
a history of vertebral fractures
surgical spinal fixation.
•any neurological disorders like MS
Trial population
Subjects: A total of 60 male \& female subjects, diagnosed with sacroiliac dysfunction participated in this study. Their BMI will from 20- 30kg/m2.
Trial design
Cohort
Prospective
Treatments tested in this trial
Electromyography (EMG)
Diagnostic testThe present study will be conducted to add a new information to the body of knowledge of physical therapy profession as it will investigate the effect of BMI on gluteus maximum activity recorded by EMG in adulthood with sacroiliac dysfunction
Treatment groups
Trial outcomes
Primary outcomes
gluteus maximum muscle activity measured by Electromyography (EMG)
weight and height will be combined to report BMI in kg/m^2)
visual analogue scale for pain
Sponsors and contacts
Click on the lead sponsor to view all of their trials.